Henry Schein, Inc. (HSIC) News

Henry Schein, Inc. (HSIC): $77.52

0.80 (+1.04%)

POWR Rating

Component Grades













Filter HSIC News Items

HSIC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HSIC News Highlights

  • HSIC's 30 day story count now stands at 46.
  • Over the past 17 days, the trend for HSIC's stories per day has been choppy and unclear. It has oscillated between 3 and 13.
  • BEAT, ABT and AGCO are the most mentioned tickers in articles about HSIC.

Latest HSIC News From Around the Web

Below are the latest news stories about Henry Schein Inc that investors may wish to consider to help them evaluate HSIC as an investment opportunity.

Nevro's (NVRO) Q4 Earnings in Line, Revenues Beat Estimates

Nevro's (NVRO) worldwide revenues fall on a year-over-year basis in Q4 due to soft geographical performances.

Yahoo | February 24, 2022

Avanos Medical (AVNS) Q4 Earnings, Revenues Top Estimates

Avanos Medical's (AVNS) fourth-quarter 2021 results gain from strength in the chronic care segment.

Yahoo | February 24, 2022

Henry Schein Announces Support for Inaugural Women in DSO® Event, ‘Empower and Grow 2022’

MELVILLE, N.Y., February 24, 2022--Henry Schein announces support for inaugural Women in DSO event, "Empower and Grow 2022."

Yahoo | February 24, 2022

Integra's (IART) Q4 Earnings Top Estimates, Gross Margin Drops

Integra (IART) records strong recovery in order demand in Q4 on broad-based strength in Neurosurgery and sales from the company's new CereLink ICP monitoring.

Yahoo | February 24, 2022

Insulet (PODD) Q4 Earnings Surpass Estimates, Margins Up

Insulet's (PODD) fourth-quarter 2021 revenues improved year over year on a strong performance of Omnipod, both in U.S. and international markets.

Yahoo | February 24, 2022

NuVasive (NUVA) Q4 Earnings Miss Estimates, Gross Margin Up

Continued strong international performance and introduction of products drove NuVasive's (NUVA) revenues in the fourth quarter of 2021.

Yahoo | February 24, 2022

Amedisys (AMED) Q4 Earnings Top Estimates, Margins Decline

Robust performances by the Home Health and Hospice segments drove Amedisys' (AMED) fourth-quarter top line.

Yahoo | February 24, 2022

Cerner (CERN) Q4 Earnings Surpass Estimates, Revenues Miss

Cerner's (CERN) fourth-quarter results benefit from gains across four of its business units.

Yahoo | February 24, 2022

LHC Group (LHCG) Q4 Earnings Miss Estimates, Revenues Beat

Despite the weak bottom-line performance, LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health admissions.

Yahoo | February 24, 2022

Abbott (ABT) COVID Testing Sales Surge, FX Headwind Stays

Abbott (ABT) registers strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

Yahoo | February 23, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7185 seconds.